BioSig Announces Submission of FDA 510(k) Application for PURE EP™ System
March 28, 2018 02:00 ET
|
BioSig Technologies, Inc.
SANTA MONICA, Calif., March 28, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB:BSGM) announced that the Company has filed 510(k) application to the U.S. Food and Drug Administration (FDA)...
ARCA biopharma Reports Topline Phase 2B Results for GENETIC-AF Clinical Trial
February 26, 2018 08:00 ET
|
ARCA biopharma, Inc.
-------------------------------------------------------------------------------------------------- Gencaro Demonstrates Comparable Efficacy to Active Control and Trend for Potential Gencaro...
BioSig Technologies to Partner with Focus Marketing
February 22, 2018 08:00 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, Feb. 22, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig Technologies to Open Operations Center in Austin, Texas
February 13, 2018 08:00 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, Feb. 13, 2018 (GLOBE NEWSWIRE) --
BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform...
Johnson & Johnson Veteran Chuck Austin To Scale Up BioSig Operations
January 09, 2018 08:00 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, Jan. 09, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
ARCA biopharma Announces Completion of GENETIC-AF Phase 2B Clinical Trial
January 08, 2018 08:30 ET
|
ARCA biopharma, Inc.
-------------------------------------------------------------------------------------------------- GENETIC-AF Evaluating Gencaro as Potentially First Genetically-Targeted Treatment for Atrial...
BioSig Technologies Appoints New Chief Financial Officer to Facilitate Growth Trajectory
January 03, 2018 08:00 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, Jan. 03, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig Technologies to Present at Digital Medicine & Medtech Showcase at Biotech Showcase
December 28, 2017 08:00 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, Dec. 28, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig Technologies Issues Shareholder Letter for 2017
December 21, 2017 08:00 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, Dec. 21, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig Technologies Adds Role of Chief Regulatory and Compliance Officer in Preparation for FDA Submission
November 14, 2017 08:00 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, Nov. 14, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...